As the architect behind GlaxoSmithKline’s (GSK) steady rise to international leader in research-based pharmaceuticals, CEO Dr. J.P. Garnier has deftly met the demands of a changing healthcare environment while still remaining true to his company’s mission — to develop innovative ways to make healthcare accessible to all.
It is an undertaking of extreme importance to Garnier and one lauded by The Greater Philadelphia Chamber of Commerce and The Fox School of Business and Management’s Institute of Global Management Studies at Temple University who honored Garnier with the prestigious 2003 Global Award on Thursday, June 12.